Anis, S., Weill, C., Ponger, P., Nassar, M., Reiner, J., Chorin, O., Parlar, S. C., Alcalay, R. N., Gan-Or, Z., Ezra, A., Saar, A., Thaler, A., Cohen, O. S., Zlotnik, Y., Benizri, S., Nitsan, Z., Djaldetti, R., Yahalom, G., Schlesinger, I., … Greenbaum, L. (2025). Genetic testing for Parkinson’s disease in Israel: Insights from the Rostock Parkinson’s Disease (ROPAD) study. Parkinsonism & Related Disorders, 137, 107940. https://doi.org/10.1016/j.parkreldis.2025.107940

Goldstein, O., Shani, S., Gana-Weisz, M., Elkoshi, N., Casey, F., Sun, Y. H., Chandratre, K., Cedarbaum, J. M., Blauwendraat, C., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Orr-Urtreger, A., & Alcalay, R. N. (2025). The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241310722

Shani, S., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., Orr-Urtreger, A., & Goldstein, O. (2024). P2RX7, an adaptive immune response gene, is associated with Parkinson’s disease risk and age at onset. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241296015

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Foroud, T., Hall, A., Marder, K. S., Mata, I. F., Mencacci, N. E., Nance, M. A., Schwarzschild, M. A., Simuni, T., Bressman, S., Wills, A.-M., Fernandez, H. H., Litvan, I., Lyons, K. E., Shill, H. A., Singer, C., … Alcalay, R. N. (2024). Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study. Brain, 147(8), 2668–2679. https://doi.org/10.1093/brain/awae142

Maayan Eshed, G., & Alcalay, R. N. (2024). GBA1-and LRRK2-directed Treatments: The Way Forward. Parkinsonism & Related Disorders, 122, 106039. https://doi.org/10.1016/j.parkreldis.2024.106039

Fan, Y., Nirujogi, R. S., Garrido, A., Ruiz-Martínez, J., Bergareche-Yarza, A., Mondragón-Rezola, E., Vinagre-Aragón, A., Croitoru, I., Gorostidi Pagola, A., Paternain Markinez, L., Alcalay, R., Hickman, R. A., Düring, J., Gomes, S., Pratuseviciute, N., Padmanabhan, S., Valldeoriola, F., Pérez Sisqués, L., Malagelada, C., … Sammler, E. M. (2021). R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils. Acta Neuropathologica, 142(3), 475–494. https://doi.org/10.1007/s00401-021-02325-z

Lai, D., Alipanahi, B., Fontanillas, P., Schwantes‐An, T., Aasly, J., Alcalay, R. N., Beecham, G. W., Berg, D., Bressman, S., Brice, A., Brockman, K., Clark, L., Cookson, M., Das, S., Van Deerlin, V., Follett, J., Farrer, M. J., Trinh, J., Gasser, T., … Foroud, T. (2021). Genomewide Association Studies of LRRK2 Modifiers of Parkinson’s Disease. Annals of Neurology, 90(1), 76–88. Portico. https://doi.org/10.1002/ana.26094

Sosero, Y. L., Yu, E., Krohn, L., Rudakou, U., Mufti, K., Ruskey, J. A., Asayesh, F., Laurent, S. B., Spiegelman, D., Fahn, S., Waters, C., Sardi, S. P., Bandres-Ciga, S., Alcalay, R. N., Gan-Or, Z., & Senkevich, K. (2021). LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease. Neurobiology of Aging, 103, 142.e1-142.e5. https://doi.org/10.1016/j.neurobiolaging.2021.02.018

Ortega, R. A., Wang, C., Raymond, D., Bryant, N., Scherzer, C. R., Thaler, A., Alcalay, R. N., West, A. B., Mirelman, A., Kuras, Y., Marder, K. S., Giladi, N., Ozelius, L. J., Bressman, S. B., & Saunders-Pullman, R. (2021). Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. JAMA Network Open, 4(4), e215845. https://doi.org/10.1001/jamanetworkopen.2021.5845